BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

795 related articles for article (PubMed ID: 33049497)

  • 1. Identification of DRP1 as a prognostic factor correlated with immune infiltration in breast cancer.
    Liu B; Fan Y; Song Z; Han B; Meng Y; Cao P; Tan K
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107078. PubMed ID: 33049497
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated analysis identifies TfR1 as a prognostic biomarker which correlates with immune infiltration in breast cancer.
    Chen F; Fan Y; Hou J; Liu B; Zhang B; Shang Y; Chang Y; Cao P; Tan K
    Aging (Albany NY); 2021 Sep; 13(17):21671-21699. PubMed ID: 34518441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated expression of FREM1 in breast cancer indicates favorable prognosis and high-level immune infiltration status.
    Li HN; Li XR; Lv ZT; Cai MM; Wang G; Yang ZF
    Cancer Med; 2020 Dec; 9(24):9554-9570. PubMed ID: 33058542
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Xiao Y; Zhang H; Du G; Meng X; Wu T; Zhou Q; Wang Y; Tan B
    Technol Cancer Res Treat; 2020; 19():1533033820970684. PubMed ID: 33176601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of ANXA1 as a potential prognostic biomarker and correlating with immune infiltrates in colorectal cancer.
    Liang Z; Li X
    Autoimmunity; 2021 Mar; 54(2):76-87. PubMed ID: 33596760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Analysis of Prognostic and Immune Infiltrates for RAD51 in Human Breast Cancer.
    Li F; Zhang Y; Shi Y; Liu S
    Crit Rev Eukaryot Gene Expr; 2021; 31(4):71-79. PubMed ID: 34587437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between prognostic indicator AHNAK2 and immune infiltrates in lung adenocarcinoma.
    Zheng M; Liu J; Bian T; Liu L; Sun H; Zhou H; Zhao C; Yang Z; Shi J; Liu Y
    Int Immunopharmacol; 2021 Jan; 90():107134. PubMed ID: 33168407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bromodomain 4 is a potent prognostic marker associated with immune cell infiltration in breast cancer.
    Zhong L; Yang Z; Lei D; Li L; Song S; Cao D; Liu Y
    Basic Clin Pharmacol Toxicol; 2021 Jan; 128(1):169-182. PubMed ID: 32799413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
    Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
    Front Immunol; 2019; 10():6. PubMed ID: 30761122
    [No Abstract]   [Full Text] [Related]  

  • 10. Prognostic value of S1PR1 and its correlation with immune infiltrates in breast and lung cancers.
    Zhong L; Xie L; Yang Z; Li L; Song S; Cao D; Liu Y
    BMC Cancer; 2020 Aug; 20(1):766. PubMed ID: 32799825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heat Shock Protein 90 Family Isoforms as Prognostic Biomarkers and Their Correlations with Immune Infiltration in Breast Cancer.
    Lin T; Qiu Y; Peng W; Peng L
    Biomed Res Int; 2020; 2020():2148253. PubMed ID: 33145341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression of JAK1 associated with immune infiltration and poor prognosis in lung adenocarcinoma.
    Cai J; Deng H; Luo L; You L; Liao H; Zheng Y
    Aging (Albany NY); 2020 Dec; 13(2):2073-2088. PubMed ID: 33323549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NEFM DNA methylation correlates with immune infiltration and survival in breast cancer.
    Li D; Zhao W; Zhang X; Lv H; Li C; Sun L
    Clin Epigenetics; 2021 May; 13(1):112. PubMed ID: 34001208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KRAS expression is a prognostic indicator and associated with immune infiltration in breast cancer.
    Liang H; Zhou G; Lv L; Lu J; Peng J
    Breast Cancer; 2021 Mar; 28(2):379-386. PubMed ID: 33067762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrative analysis of prognostic value and immune infiltration of spindle and kinetochore-associated family members in breast cancer.
    Ding J; He X; Wang J; Cao G; Chen S; Yuan L; Chen B; Xiong M
    Bioengineered; 2021 Dec; 12(2):10905-10923. PubMed ID: 34845974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel Immune and Stroma Related Prognostic Marker for Invasive Breast Cancer in Tumor Microenvironment: A TCGA Based Study.
    Huang Y; Chen L; Tang Z; Min Y; Yu W; Yang G; Zhang L
    Front Endocrinol (Lausanne); 2021; 12():774244. PubMed ID: 34867821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of eIF4E is associated with tumor macrophage infiltration and leads to poor prognosis in breast cancer.
    Li F; Sun H; Li Y; Bai X; Dong X; Zhao N; Meng J; Sun B; Zhang D
    BMC Cancer; 2021 Dec; 21(1):1305. PubMed ID: 34876062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer.
    Shi S; Ye S; Mao J; Ru Y; Lu Y; Wu X; Xu M; Zhu T; Wang Y; Chen Y; Tang X; Xi Y
    Autoimmunity; 2020 Jun; 53(4):210-217. PubMed ID: 32129682
    [No Abstract]   [Full Text] [Related]  

  • 19.
    Hu Z; Qu S
    Front Immunol; 2021; 12():683572. PubMed ID: 34267752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTP4A3 Is a Prognostic Biomarker Correlated With Immune Infiltrates in Papillary Renal Cell Carcinoma.
    Song Q; Zheng Y; Wu J; Wang S; Meng L; Yao Q; Li Z; Lian S
    Front Immunol; 2021; 12():717688. PubMed ID: 34630392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.